- Open Access
Erratum to: Impact of intravenous fluid composition on outcomes in patients with systemic inflammatory response syndrome
Critical Carevolume 20, Article number: 17 (2016)
The original article was published in Critical Care 2015 19:334
After the publication of this article it has been brought to our attention that the data in Table 3 (Table 1 in this Erratum) and in the Additional file 3: Table S3 (Additional File 1 in this Erratum) contained mistakes as detailed below. These mistakes have been corrected in this Erratum.
The following values have been corrected in Table 3 (Table 1 in this Erratum):
the entire column (far right) "Adjusted Odds Ratio (95 % CI)"
under Electrolyte Abnormalities, the value for "High Mg" within the column "Saline n (%)" and the values for "Unadjusted Odds Raio (95 % CI)" and "Adjusted Odds Ratio (95 % CI)"
under Electrolyte Abnormalities, ALL values for the row labelled "Low Ca with replacement"
The single value for SOFA CV Level 2 "Saline cohort n (%)" in Table S3 (Additional File 1 in this Erratum) has been corrected.
In addition, we noticed that the legend for Fig. 2 (Fig. 1 in this Erratum) was incorrectly given as “Administrative and clinical outcomes unadjusted and adjusted for Acute Physiology Score”. The correct legend for Fig. 2 is “Administrative and clinical outcomes unadjusted and adjusted for APS, Elixhauser comorbidities of congestive heart failure, hypertension and lymphoma, admission source, census region, and payer.” The labels above the right-hand side plots within the figure also needed corrections and have been updated in this erratum.
Shaw AD, Schermer CR, Lobo DN, Munson SH, Khangulov V, Hayashida DK, et al. Impact of intravenous fluid composition on outcomes in patients with systemic inflammatory response syndrome. Critical Care. 2015;19:334.
The online version of the original article can be found under doi:10.1186/s13054-015-1045-z.
SOFA Outcomes by Treatment Group. (DOCX 12 kb)